Update of the common package of benefits of the Spanish National Health System

29

May 2019

In April 2019, the Ministry of Health, Consumption and Social Welfare announced the update of the common package of benefits of the Spanish national health system (NHS) with the inclusion of cervical cancer screening, nipple and areola micropigmentation and update of orthoprosthesis catalog. 

The new measures offer new benefits aimed primarily at children, women, and people with disabilities. The order will come into force on July 1, 2019, and grants a period of six months to be fully implemented.  The implementation of the new services will result in an estimated saving for the NHS of €20.5 million per year due to the positive impact of screening in the prevention and early detection of cervical cancer.

Cervical cancer screening:

The screening will be done to 25-65 years old women. For women aged 25-34 years through cytology, every three years, and for women aged 35-65 years through the determination of high-risk human papillomavirus. In this case, if the test is negative, the test will be repeated 5 years later. If it is positive, cytology will be performed.

Nipple and areola micropigmentation after breast cancer:

Regarding mastectomized women, nipple and areola micropigmentation are considered part of breast reconstruction in order to guarantee that this benefit is offered homogeneously throughout the Spanish NHS.

Eye reader to interact with computers in people with severe motor disability

An eye reader or other similar communication system is to be provided to patients with severe neuromotor disorders with the involvement of both upper limbs and the inability to communicate orally or in writing. This is intended to grant greater autonomy and quality of life to these patients.

Update of orthoprosthesis catalog:

The new order details and updates the common catalog of orthoprosthetic provision in relation to prostheses other than those of the upper and lower members. In total, 58 types of products are included. Among them, breast prostheses and facial restoration, hearing aids, as well as replacements of external components of surgical implants.

In addition, the age of funding for hearing aids is increased, from the current 16 years old, to the 26 years, gradually.

See the press release by the Ministry of Health, Consumption and Social Welfare here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

04

Mar 2022

On February 14, 2022, the Danish Treatment Council (Behandlingsråd), a new body for assessing treatments and health technologies that became fully operational in late May 2021, has announced its symposium, which will take place in Aalborg on May 11, 2022.

Read more

24

Feb 2022

On January 18, 2022, the Ministry of Health has awarded the Framework Agreement for the acquisition of 81 linear accelerators included in the High-End Technology Equipment Investment Plan. Furthermore, the National Institute of Health Management (INGESA) has also initiated the processing of the Framework Agreement that will facilitate the acquisition of the equipment in the fields of interventional cardiology, interventional vascular radiology, interventional neurovascular, digital brachytherapy, computed tomography, magnetic resonance imaging, PET-CT, SPECT-CT.

Read more

15

Feb 2022

In January 2022, the Basque Office for Health Technology Assessment (OSTEBA) released an HTA report aiming to assess and compare the efficacy, effectiveness, and safety of the mechanical circulatory support devices most used in the healthcare setting for the treatment and prevention of cardiogenic shock, including Impella® devices, intra-aortic balloon pumps, and extracorporeal membrane oxygenation.

Read more